GLENMARK PHARMS LTD FDA Approval ANDA 204771

ANDA 204771

GLENMARK PHARMS LTD

FDA Drug Application

Application #204771

Application Sponsors

ANDA 204771GLENMARK PHARMS LTD

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002

Application Products

001POWDER;IV (INFUSION)25MG/VIAL0BENDAMUSTINE HYDROCHLORIDEBENDAMUSTINE HYDROCHLORIDE
002POWDER;IV (INFUSION)100MG/VIAL0BENDAMUSTINE HYDROCHLORIDEBENDAMUSTINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1TA2019-02-20STANDARD

Submissions Property Types

ORIG1Null1

CDER Filings

GLENMARK PHARMS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204771
            [companyName] => GLENMARK PHARMS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"BENDAMUSTINE HYDROCHLORIDE","activeIngredients":"BENDAMUSTINE HYDROCHLORIDE","strength":"25MG\/VIAL","dosageForm":"POWDER;IV (INFUSION)","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"BENDAMUSTINE HYDROCHLORIDE","activeIngredients":"BENDAMUSTINE HYDROCHLORIDE","strength":"100MG\/VIAL","dosageForm":"POWDER;IV (INFUSION)","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/20\/2019","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-02-20
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.